Action of clofazimine on the Mycobacterium avium complex

Research in Microbiology

Volumn 147, Issue 1-2, 1996, Pages 43-48

  Warek, U ^a   Falkinham III, J O ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CAROTENOID; CLOFAZIMINE; OXYGEN; SUPEROXIDE;

ANTIBACTERIAL ACTIVITY; CONFERENCE PAPER; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; MYCOBACTERIOSIS; MYCOBACTERIUM AVIUM; NONHUMAN; OXYGEN CONSUMPTION; PIGMENTATION; PRIORITY JOURNAL;

EID: 0029988592     PISSN: 09232508     EISSN: None     Source Type: Journal    
DOI: 10.1016/0923-2508(96)80202-6     Document Type: Conference Paper

References (27)

1. Agins, B.D., Berman, D.S., Spicehandler, D., El-Sadr, W., Simberkoff, M.S. & Rahal, J.J. (1989), Effect of combined therapy with ansamycin, clofazimine, ethambutol, and isoniazid for Mycobacterium avium infection in patients with AIDS. J. Infect. Dis., 159, 784-787.
2. Barry, V.C., Buggle, K., Byrne, H., Conalty, M.L. & Winder, F. (1959), Factors influencing the antituberculous activity of the rimino-compounds. Bull. Int. Union Tuberc., 29, 582-593.
3. Benson, C.A., Kellser, H.A., Pottage, J.C. & Trenholme, G.M. (1991), Successful treatment of acquired immunodeficiency syndrome-related Mycobacterium avium complex disease with a multiple drug regimen including amikacin. Arch. Intern. Med., 151, 582-585.
4. Burton, G.W. & Ingold, K.U. (1984), β-carotene: an unusual type of lipid antioxidant. Science, 224, 569-572.
5. Crawford, J.T., Cave, M.D. & Bates, J.H. (1981), Evidence for plasmid-mediated restriction-modification in Mycobacterium avium-intracellulare. J. Gen. Microbiol., 127, 333-338.
6. David, H.L., Rastogi, N., Clavel-Sérès, S. & Clément, F. (1987), Studies on clofazimine-resistance in mycobacteria: is the inability to isolate drug-resistance mutants related to its mode of action? Zbl. Bakt. Hyg. A, 266, 292-304.
7. Ellner, J.J., Goldberger, M.J. & Parenti, D.M. (1991), Mycobacterium avium infection and AIDS: a therapeutic dilemma in rapid evolution. J. Infact. Dis., 163, 1326-1335.
8. Gangadharam, P.R.J., Perumal, V.K., Podapati, N.P., Kesavalu, L. & Iseman, M.D. (1988), In vivo activity of amikacin alone or in combination with clofazimine or rifabutin or both against acute experimental Mycobacterium avium complex infections in beige mice. Antimicrob. Agents Chemother., 32, 1400-1403.
9. George, K.L., Falkinham, J.O., III (1989), Identification of cytoplasmic membrane protein antigens of Mycobacterium avium, M. intracellulare and M. scrofulaceum. Can. J. Microbiol., 35, 529-534.
10. Hassan, H.M. & Fridovich, I. (1980), Mechanism of the antibiotic action of pyocyanine. J. Bacteriol., 141, 156-163.
11. Horsburgh, C.R. & Selik, R. (1989), The epidemiology of disseminated nontuberculous mycobacterial infection in the acquired immunodeficiency syndrome (AIDS). Am. Rev. Respir. Dis., 139, 4-7.
12. Imlay, J.A. & Fridovich, I. (1991), Assay of metabolic superoxide production in Escherichia coli. J. Biol. Chem., 266, 6957-6965.
13. Kapoor, V.K. (1989), Clofazimine. Anal. Profiles Drug Substances, 18, 91-120.
14. Karat, A.B.A., Jeevaratnam, A., Karat, S. & Rao, P.S.S. (1971), Controlled clinical trial of clofazimine in untreated lepromatous leprosy. Br. Med. J., 4, 514-516.
15. Klemens, S.P. & Cynamon, M.H. (1991), In-vivo activities of newer rifamycin analogs against Mycobacterium avium infection. Antimicrob. Agents Chemother., 35, 2026-2030.
16. Lowry, O.H., Rosebrough, N.J., Farr, A. & Randall, R.J. (1951), Protein measurement with the Folin phenol reagent. J. Biol. Chem., 193, 265-275.
17. Mayer, B.K. & Falkinham, J.O., III (1986a), Superoxide dismutase activity of Mycobacterium avium, Mycobacterium intracellulare and Mycobacterium scrofulaceum. Infect. Immun., 53, 631-635.
18. Mayer, B.K. & Falkinham, J.O., III (1986b), Catalase activity and its heat inactivation for differentiation of Mycobacterium avium, Mycobacterium intracellulare and Mycobacterium scrofulaceum. Int. J. System. Bacteriol., 36, 207-212.
19. Mazur, H., Tuazon, C., Gill, V., Grimes, G., Baird, B., Faucin, A.S. & Lane, H.C. (1987), Effect of combined clofazimine and ansamycin therapy on Mycobacterium avium - Mycobacterium intracellulare bacteremia in patients with AIDS. J. Infect. Dis., 155, 127-129.
20. Nishikimi, M., Rao, N.A. & Yagi, K. (1972), The occurrence of superoxide anion in the reaction of reduced phenazine methosulfate and molecular oxygen. Biochem. Biophys. Res. Commun., 46, 849-854.
21. Pethel, M.L. & Falkinham, J.O., III (1989), Plasmid-influenced changes in Mycobacterium avium catalyse activity. Infect. Immun., 57, 1714-1718.
22. Rhodes, P.M. & Wilkie, D. (1973), Antimicrobial activity of lamprene in Saccharomyces cerevisiae. Biochem. Pharmacol., 22, 1047-1056.
23. Robinson, J. & Cooper, J.M. (1970), Method of determining oxygen concentrations in biological media, suitable for calibration of the oxygen electrode. Anal. Biochem., 33, 390-399.
24. Sahu, A., Saha, K., Banerjee, N.R., Sehgal, V.N. & Jagga, C.R. (1991), Effect of anti-leprosy drugs on superoxide anion production by rat peritoneal macrophage with special reference to light exposed clofazimine. Int. J. Immunopharmacol., 13, 419-428.
25. Stormer, R.S. & Falkinham, J.O., III (1989), Differences in antimicrobial susceptibility of pigmented and unpigmented colonial variants of Mycobacterium avium. J. Clin. Microbiol., 27, 2459-2465.
26. Winder, F.G. (1982), Mode of action of the antimycobacterial agents and associated aspects of the molecular biology of the mycobacteria, in "The biology of the mycobacteria". (C. Ratledge & J. Stanford, Vol. 1) (pp. 354-438). Academic Press, London.
27. Young, L.S. (1988), Mycobacterium avium complex infection. J. Infect. Dis., 157, 863-867.